Category: Articles

How to Purchase TCAD (TrueCAD) on Crypto.com

Today, we’re going to outline how to buy TCAD (TrueCAD) tokens on Crypto.com.

Continue reading “How to Purchase TCAD (TrueCAD) on Crypto.com”

How to Purchase TCAD (TrueCAD) and Transfer it to the Celsius Network

Today, we’re going to outline how to buy TCAD (TrueCAD) tokens and transfer them to Celsius in the cheapest and most efficient manner.

We are going to utilize Crypto.com to purchase the TCAD tokens as it is currently the best method to purchase and transfer TCAD tokens.

Continue reading “How to Purchase TCAD (TrueCAD) and Transfer it to the Celsius Network”

Can Score Media and Gaming (SCR.TO) revolutionize single-event sports betting?

As of today, single-event sports betting is illegal in Canada. If Canadians would like to legally bet on sports, they are currently forced to play “parlay” bets. Parlay bets are defined as a sports bet in which you combine multiple individual bets into one “card”. Many Canadians have chosen to risk their money and bet on single-events sports on the black market. According to estimates from the CBC, Canadians are betting $14 billion per year through illegal channels.

Will psychedelics replace cannabis as the next big thing?

Over the last year, there has been a dramatic increase in interest for psychedelic stocks. The main psychedelic stocks that people have been searching for include:

  • NUMI.V – Numinus Wellness Inc.
  • MMED.NE – Mind Medicine (MindMed) Inc.
  • RVV.CN – Revive Therapeutics Ltd
  • TRIP.CN – Red Light Holland Corp.
  • HAVN.CN – HAVN Life Sciences Inc.
  • CYBN.NE – Cybin Inc.
  • MYCO.CN – Mydecine Innovations Group Inc.

The Genomics Revolution ETF (ARKG). Can it outperform Tesla (TSLA)?

Recently, there has been an increase in interest in the genomics industry. The main reason for this has been the ARKG ETF, which Cathie Wood manages. The ARKG ETF has the following description:

“This actively managed equity strategy seeks long-term capital growth by investing in the US listed securities, including ADRs, of companies focused on the genomics revolution. Companies within this strategy aim to capture the substantial benefits of new products and services associated with technological and scientific developments in DNA sequencing, gene editing, targeted therapeutics, bioinformatics, and agricultural biology.”